UBS Group’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,315
| Closed | -$2.3K | – | 9133 |
|
|
2023
Q1 | $2.3K | Buy |
1,315
+323
| +33% | +$564 | ﹤0.01% | 7435 |
|
|
2022
Q4 | $1.88K | Buy |
992
+611
| +160% | +$1.16K | ﹤0.01% | 8576 |
|
|
2022
Q3 | $1K | Sell |
381
-886
| -70% | -$2.33K | ﹤0.01% | 9142 |
|
|
2022
Q2 | $6K | Buy |
1,267
+36
| +3% | +$170 | ﹤0.01% | 7777 |
|
|
2022
Q1 | $13K | Buy |
+1,231
| New | +$13K | ﹤0.01% | 7087 |
|
|
2020
Q2 | – | Sell |
-22
| Closed | -$3K | – | 7525 |
|
|
2020
Q1 | $3K | Buy |
+22
| New | +$3K | ﹤0.01% | 6644 |
|
|
2019
Q4 | – | Sell |
-28
| Closed | -$14K | – | 7351 |
|
|
2019
Q3 | $14K | Sell |
28
-18
| -39% | -$9K | ﹤0.01% | 6012 |
|
|
2019
Q2 | $28K | Buy |
46
+5
| +12% | +$3.04K | ﹤0.01% | 5527 |
|
|
2019
Q1 | $25K | Sell |
41
-109
| -73% | -$66.5K | ﹤0.01% | 5301 |
|
|
2018
Q4 | $55K | Buy |
150
+100
| +200% | +$36.7K | ﹤0.01% | 5120 |
|
|
2018
Q3 | $34K | Sell |
50
-30
| -38% | -$20.4K | ﹤0.01% | 5551 |
|
|
2018
Q2 | $69K | Buy |
80
+9
| +13% | +$7.76K | ﹤0.01% | 4854 |
|
|
2018
Q1 | $90K | Buy |
71
+52
| +274% | +$65.9K | ﹤0.01% | 4454 |
|
|
2017
Q4 | $29K | Buy |
19
+14
| +280% | +$21.4K | ﹤0.01% | 5310 |
|
|
2017
Q3 | $10K | Buy |
+5
| New | +$10K | ﹤0.01% | 5998 |
|
|
2017
Q1 | – | Sell |
-5
| Closed | -$7K | – | 6939 |
|
|
2016
Q4 | $7K | Buy |
+5
| New | +$7K | ﹤0.01% | 6144 |
|
|
2016
Q2 | – | Sell |
-5
| Closed | -$12K | – | 7004 |
|
|
2016
Q1 | $12K | Hold |
5
| – | – | ﹤0.01% | 5713 |
|
|
2015
Q4 | $13K | Buy |
+5
| New | +$13K | ﹤0.01% | 5870 |
|